Money Back Guarantee on Expensive Drugs?

In 2017, the United States could see their first gene therapy drugs hit the market, but at what cost? Currently, hepatitis C treatments capable of curing this disease and saving untold dollars in the long run but the high, upfront costs have led to rationing by many budget-strapped states. One suggestion is to have the drug maker issue a refund or make them pay for additional rounds of treatment if the pricey therapy eventually stops working. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.